XNCR- Xencor, Inc.
Xencor, Inc. (XNCR) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. XNCR is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 477.3K | $9.55M | - | |
| CFO | 75.9K | $1.52M | - | |
| Dir | 30.0K | $599.5K | - | |
| Dir | 25.8K | $517.0K | - | |
| Dir | 25.0K | $500.2K | - |
Activity
Buys and sells only
Transactions
10 filings · page 2
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2025 | Feigal Ellen | Director | Sell | 2,993 | $9.22 | $27,595.46 | -13.5% | -6.2% | +34.8% | |
| Jun 16, 2025 | Ranieri Richard J | Director | Sell | 2,993 | $9.22 | $27,595.46 | -13.5% | -6.2% | +34.8% | |
| May 2, 2025 | Valente Nancy61 | EVP, Chief Development Officer | Sell | 4,616 | $11.03 | $50,914.48 | -8.6% | -26.1% | +12.7% | |
| Apr 10, 2025 | Cornelissen Bart Jan | Sr. Vice President &CFO | Sell | 3,750 | $8.06 | $30,232.87 | -5.8% | +17.8% | +56.8% | |
| Mar 10, 2025 | Valente Nancy61 | EVP, Chief Development Officer | Sell | 2,565 | $13.60 | $34,876.56 | -4.6% | -29.9% | -12.0% | |
| Mar 10, 2025 | Eckert Celia71 | SVP, General Counsel | Sell | 5,740 | $13.60 | $78,047.35 | -8.3% | -29.9% | -12.0% | |
| Mar 10, 2025 | Desjarlais John R76 | Sr. Vice President &CSO | Sell | 9,697 | $13.60 | $131,851.08 | -3.9% | -29.9% | -12.0% | |
| Mar 10, 2025 | Dahiyat Bassil I74 | President &CEO | Sell | 19,716 | $13.60 | $268,080.42 | -4.1% | -29.9% | -12.0% | |
| Dec 4, 2024 | Montgomery Alan Bruce62 | Director | Sale+OE | 14,722 | $27.03 | $397,930.92 | -44.6% | -46.0% | -30.8% | |
| Nov 21, 2024 | Dahiyat Bassil I74 | President &CEO | Sale+OE | 49,278 | $24.07 | $1,186,362.92 | -12.3% | -32.8% | -34.1% |